Chemed (CHE) CEO Joel Wherley details PSU vesting, 0% TSR payout
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Chemed Corp CEO Joel L. Wherley reported equity compensation activity tied to performance stock units on February 13, 2026. He acquired 273 shares of capital stock through the exercise of PSUs at an exercise price of $469.56 per share and had 852 shares of capital stock directly owned afterward. The company’s cumulative adjusted earnings per share of $67.67 for the 2023–2025 period exceeded the $66.46 maximum payout threshold, resulting in a PSU payout of 123% of target, or 124.1% including dividend reinvestment. A separate PSU award based on relative total shareholder return for the same period paid out at 0% of target.
Positive
- None.
Negative
- None.
Insider Trade Summary
440 shares exercised/converted
Mixed
6 txns
Insider
Wherley Joel L
Role
CEO - Vitas Healthcare
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units | 220 | $0.00 | -- |
| Exercise | Performance Stock Units | 220 | $0.00 | -- |
| Grant/Award | Performance Stock Units | 1,142 | $0.00 | -- |
| Exercise | Capital Stock | 273 | $469.56 | $128K |
| Exercise | Capital Stock | 0 | $469.56 | -- |
| Tax Withholding | Capital Stock | 80 | $469.56 | $38K |
Holdings After Transaction:
Performance Stock Units — 1,290 shares (Direct);
Capital Stock — 932 shares (Direct)
Footnotes (1)
- The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target. The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target. Shares withheld to satisfy tax obligations in connection with vesting of PSUs. Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee. PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026. Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.
